Curis, Inc. (CRIS) vs Finch Therapeutics Group, Inc. (FNCHQ)
Curis, Inc. and Finch Therapeutics Group, Inc. are both Biotechnology companies. Curis, Inc. is the larger, with a market value of $1.8M against $1.6M — 1.2× the size. Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −96.0%. Across the 12 metrics below, Curis, Inc. leads on 7 and Finch Therapeutics Group, Inc. on 5.
Valuation
Profitability
| Metric | CRIS | FNCHQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.52% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 455.35% | (67.28%) | (57.72%) |
| Return on assets | (87.76%) | (25.20%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack